Skip to main content

Antifungal Susceptibility Tests of Aspergillus Species

  • Chapter
  • First Online:
Aspergillosis: From Diagnosis to Prevention

Abstract

Although different methods are now available to assess the susceptibility of Aspergillus species to antifungal agents, there are still limited data correlating in vitro resistance with meaningful clinical endpoints. Moreover, there is no consensus on the breakpoints to define resistance/susceptibility to different antifungal agents. This chapter reviews the technical issues related to antifungal susceptibility tests for Aspergillus species, including the use of control strains, inoculum preparation, culture media, and incubation conditions.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 259.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Sherris, J. C. (1989) Antimicrobic susceptibility testing. A personal perspective. Clin Lab Med, 9, 191–202.

    CAS  PubMed  Google Scholar 

  2. Denning, D. W. (2003) Echinocandin antifungal drugs. Lancet, 362: 1142–51.

    Article  CAS  PubMed  Google Scholar 

  3. Maertens, J. A. (2004) History of the development of azole derivatives. Clin Microbiol Infec , 10, 1–10.

    Article  CAS  Google Scholar 

  4. Boucher, H. W., Groll, A. H., Chiou, C. C. & Walsh, T. J. (2004) Newer systemic antifungal agents: pharmacokinetics, safety and efficacy. Drugs, 64: 1997–2020.

    Article  Google Scholar 

  5. Arikan, S. (2007) Current status of antifungal susceptibility testing methods. Med Mycol, 45, 569–87.

    Article  CAS  PubMed  Google Scholar 

  6. Espinel-Ingroff, A. (2008) Mechanisms of resistance to antifungal agents: yeasts and filamentous fungi. Rev Iberoam Micol, 25, 101–6.

    Article  PubMed  Google Scholar 

  7. Kanafani, Z. A. & Perfect, J. R. (2008) Antimicrobial resistance: resistance to antifungal agents: mechanisms and clinical impact. Clin Infect Dis, 46, 120–8.

    Article  PubMed  Google Scholar 

  8. Da Silva, M. E., Capellaro, J. L., Dos Reis Marques, E., Malavazi, I., Perlin, D., Park, S., Anderson, J. B., Colombo, A. L., Arthington-Skaggs, B. A., Goldman, M. H. & Goldman, G. H. (2004) In vitro evolution of itraconazole resistance in Aspergillus fumigatus involves multiple mechanisms of resistance. Antimicrob Agents Chemother, 48, 4405–13.

    Article  Google Scholar 

  9. Chen, J., Li, H., Li, R., Bu, D. & Wan, Z. (2005) Mutations in the cyp51A gene and susceptibility to itraconazole in Aspergillus fumigatus serially isolated from a patient with lung aspergilloma. J Antimicrob Chemother, 55, 31–7.

    Article  CAS  PubMed  Google Scholar 

  10. Slaven, J. W., Anderson, M. J., Sanglard, D., Dixon, G. K., Billie, J., Roberts, I. S. & Denning, D. W. (2002) Increased expression of a novel Aspergillus fumigatus ABC transporter gene, atrF, in the presence of itraconazole in an itraconazole resistant clinical isolate. Fungal Genet Biol, 36, 199–206.

    Article  CAS  PubMed  Google Scholar 

  11. Mann, P. A., Parmegiani, R. M., Wei, S. Q., Mendrick, C. A., Loebenberg, D., Didomenico, B., Hare, R. S., Walker, S. S. & Mcnicholas, P. M. (2003) Mutations in Aspergillus fumigatus resulting in reduced susceptibility to posaconazole appear to be restricted to a single amino acid in the cytochrome P450 14alphademethylase. Antimicrob Agents Chemother, 47, 577–81.

    Article  CAS  PubMed  Google Scholar 

  12. Mellado, E., Garcia-Effron, G., Alcazar-Fuoli, L., Cuenca-Estrella, M. & Rodriguez-Tudela, J. L. (2004) Substitutions at methionine 220 in the 14 alphasterol demethylase (Cyp51A) of Aspergillus fumigatus are responsible for resistance in vitro to azole antifungal drugs. Antimicrob Agents Chemother, 48, 2747–50.

    Article  CAS  PubMed  Google Scholar 

  13. Mellado, E., Garcia-Effron, G., Alcazar-Fuoli, L., Melchers, W. J., Verweij, P. E., Cuenca-Estrella, M. & Rodríguez-Tudela, J. L. (2007) A new Aspergillus fumigatus resistance mechanism conferring in vitro cross-resistance to azole involves a combination of cyp51A alterations. Antimicrob Agents Chemother, 51, 1897–904.

    Article  CAS  PubMed  Google Scholar 

  14. Clinical and Laboratory Standards Institute – CLSI. (2002) Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. Approved standard M38-A. Wayne, Pa.

    Google Scholar 

  15. Lass-Flörl, C., Nagl, M., Speth, C., Ulmer, H., Dierich, M. P. & Würzner, R. (2001) Studies of in vitro activities of voriconazole and itraconazole against Aspergillus hyphae using viability staining. Antimicrob Agents Chemother, 45, 124–8.

    Article  PubMed  Google Scholar 

  16. Perkhofer, S., Lugger, H., Dierich, M. P. & Lass-Flörl, C. (2007) Posaconazole enhances the activity of amphotericin B against Aspergillus hyphae in vitro. Antimicrob Agents Chemother, 51, 791–3.

    Article  CAS  PubMed  Google Scholar 

  17. Guarro, J., Llop, C., Aguilar, C. & Pujol, I. (1997) Comparison of in vitro antifungal susceptibilities of conidia and hyphae of filamentous fungi. Antimicrob Agents Chemother, 41, 2760–2

    CAS  PubMed  Google Scholar 

  18. Espinel-Ingroff, A. & Kerkering, T. M. (1991) Spectrophotometric method of inoculum preparation for the in vitro susceptibility testing of filamentous fungi. J Clin Microbiol, 29, 393–4.

    CAS  PubMed  Google Scholar 

  19. Espinel-Ingroff, A., Dawson, K., Pfaller, M., Anaissie, E., Breslin, B., Dixon, D., Fothergill, A., Paetznick, V., Peter, J., Rinaldi, M. & Walsh, T. (1995) Comparative and collaborative evaluation of standardisation of antifungal susceptibility testing for filamentous fungi. Antimicrob Agents Chemother, 39, 314–9.

    CAS  PubMed  Google Scholar 

  20. Espinel-Ingroff, A., Fothergill, A., Ghannoum, M., Manavathu, E., Ostrosky-Zeichner, L., Pfaller, M., Rinaldi, M., Schell, W. & Walsh, T. (2005) Quality control and reference guidelines for CLSI broth microdilution susceptibility method (M 38-A document) for amphotericin B, itraconazole, posaconazole, and voriconazole. J Clin Microbiol, 43, 5243–6.

    Article  CAS  PubMed  Google Scholar 

  21. Manavathu, E. K., Chandrasekar, P. H., Abraham, O. C., Nune, U. & Kanuri, K. (2000) Effect of test medium on in vitro susceptibility testing results for Aspergillus fumigatus. Rev Iberoam Micol, 17, 107–10.

    PubMed  Google Scholar 

  22. Clinical and Laboratory Standards Institute – CLSI. (1992) Reference method for broth dilution antifungal susceptibility testing of yeasts. Proposed standard M27-P, Villanova, Pa.

    Google Scholar 

  23. Espinel-Ingroff, A., Bartlett, M., Bowden, R., Chin, N. X., Cooper, C. Jr., Fothergill, A., Mcginnis, M. R., Menezes, P., Messer, S. A., Nelson, P. W., Odds, F. C., Pasarell, L., Peter, J., Pfaller, M. A., Rex, J. H., Rinaldi, M. G., Shankland, G. S., Walsh, T. J. & Weitzman, I. (1997) Multicenter evaluation of proposed standardized procedure for antifungal susceptibility testing of filamentous fungi. J Clin Microbiol, 35, 139–43.

    CAS  PubMed  Google Scholar 

  24. Clinical and Laboratory Standards Institute – CLSI. (2001) Development of in vitro susceptibility testing criteria and quality control parameters. Aproved guideline, 2nd ed. NCCLS document M23-A2. Clinical and Laboratory Standars Institute, Villanova, Pa.

    Google Scholar 

  25. Clinical and Laboratory Standards Institute – CLSI. (2008) Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. Approved standard –2nd ed. M38-A2. Wayne, Pa.

    Google Scholar 

  26. Pfaller, M. A., Messer, S. A. & Coffmann, S. (1995) Comparison of visual and spectrophotometric methods of MIC endpoint determinations by using broth microdilution methods to test five antifungal agents, including the new triazole D0870. J Clin Microbiol, 33, 1094–7.

    CAS  PubMed  Google Scholar 

  27. Espinel-Ingroff, A. (2001) Comparison of the E-test with the NCCLS M38-P method for antifungal susceptibility testing of common and emerging pathogenic filamentous fungi. J Clin Microbiol, 39, 1360–7.

    Article  CAS  PubMed  Google Scholar 

  28. Lass-Flörl, C. & Perkhofer, S. (2008) In vitro susceptibility-testing in Aspergillus species. Mycoses, 51, 437–46.

    Article  PubMed  Google Scholar 

  29. Kurtz, M. B., Heath, I.B., Marrinan, J., Dreikorn, S., Onishi, J. & Douglas, C. (1994) Morphological effects of lipopeptides against Aspergillus fumigatus correlate with activities against (1,3)-beta-D-glucan synthase. Antimicrob Agents Chemother, 38, 1480–9.

    CAS  PubMed  Google Scholar 

  30. González, G. M., Tijerina, R., Najvar, L. K., Bocanegra, R., Luther, M., Rinaldi, M. G. & Graybill, J. R. (2001) Correlation between antifungal susceptibilities of Coccidioides immitis in vitro and antifungal treatment with caspofungin in a mouse model. Antimicrob Agents Chemother, 45, 1854–9.

    Article  PubMed  Google Scholar 

  31. Clinical and Laboratory Standards Institute – CLSI. (1997) Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard M27-A, Wayne, Pa.

    Google Scholar 

  32. Chryssanthou, E. & Cuenca-Estrella, M. (2006) Comparison of the EUCAST-AFST broth dilution method with the CLSI reference broth dilution method (M38-A) for susceptibility testing of posaconazole and voriconazole against Aspergillus spp. Clin Microbiol Infect, 12, 901–4.

    Article  CAS  Google Scholar 

  33. Denning, D. W., Radford, S. A., Oakley, K. L., Hall, L., Johnson, E. M. & Warnock, D. W. (1997) Correlation between in-vitro susceptibility testing to itraconazole and in-vivo outcome of Aspergillus fumigatus infection. J Antimicrob Chemother, 40, 401–14.

    Article  CAS  PubMed  Google Scholar 

  34. Petrikkou, E., Rodríguez-Tudela, J. L., Cuenca-Estrella, M., Gómez, A., Molleja, A. & Mellado, E. (2001) Inoculum standardisation for antifungal susceptibility testing of filamentous fungi pathogenic for humans. J Clin Microbiol, 39, 1345–7.

    Article  CAS  PubMed  Google Scholar 

  35. Aberkane, A., Cuenca-Estrella, M., Gomez-Lopez, A., Petrikkou, E., Mellado, E., Monzón, A. & Rodriguez-Tudela, J. L. (2002) Comparative evaluation of two different methods of inoculum preparation for antifungal susceptibility testing of filamentous fungi. J Antimicrob Chemother, 50, 719–22.

    Article  CAS  PubMed  Google Scholar 

  36. Rodriguez-Tudela, J. L., Chryssanthou, E., Petrikkou, E., Mosquera, J., Denning, D. W. & Cuenca-Estrella, M. (2003) Interlaboratory evaluation of hematocytometer method of inoculum preparation for testing antifungal susceptibilities of filamentous fungi. J Clin Microbiol, 41, 5236–7.

    Article  CAS  PubMed  Google Scholar 

  37. Rodriguez-Tudela, J. L., Alcazar-Fuoli, L., Alastruey-Izquierdo, A., Monzon, A., Mellado, E. & Cuenca-Estrella, M. (2007) Time of incubation for antifungal susceptibility testing of Aspergillus fumigatus: can MIC values be obtained at 24 hours? Antimicrob Agents Chemother, 51, 4502–4.

    Article  CAS  PubMed  Google Scholar 

  38. Cuenca-Estrella, M., Arendrup, M. C., Chryssanthou, E., Dannaoui, E., Lass-Florl, C., Sandven, P., Velegraki, A. & Rodriguez-Tudela, J. L.; AFST Subcommittee of EUCAST. (2007) Multicentre determination of quality control strains and quality control ranges for antifungal susceptibility testing of yeasts and filamentous fungi using the methods of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antimicrobial Susceptibility Testing (AFST-EUCAST). Clin Microbiol Infect, 13, 1018–22.

    Article  CAS  PubMed  Google Scholar 

  39. Subcommittee on Antifungal Susceptibility Testing of the ESCMID European Committee for Antimicrobial Susceptibility Testing. (2008) EUCAST Technical Note on the method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for conidia-forming moulds. Clin Microbiol Infect, 14, 982–4.

    Article  Google Scholar 

  40. Colombo, A. L., Barchiesi, F., Mcgough, D. A. & Rinaldi, M. G. (1995) Comparison of Etest and National Committee for Clinical Laboratory Standards broth macrodilution method for azole antifungal susceptibility testing. J Clin Microbiol, 33, 535–40.

    CAS  PubMed  Google Scholar 

  41. Szekely, A., Johnson, E. M. & Warnock, D. W. (1999) Comparison of E-test and broth microdilution methods for antifungal drug susceptibility testing of molds. J Clin Microbiol, 37, 1480–3.

    CAS  PubMed  Google Scholar 

  42. Matar, M. J., Ostrosky-Zeichner, L., Paetznick, V. L., Rodriguez, J. R., Chen, E. & Rex, J. H. (2003) Correlation between E-test, disk diffusion and microdilution methods for antifungal susceptibility testing of fluconazole and voriconazole. Antimicrob Agents Chemother, 47, 1647–51.

    Article  CAS  PubMed  Google Scholar 

  43. Espinel-Ingroff, A., Arthington-Skaggs, B., Iqbal, N., Ellis, D., Pfaller, M. A., Messer, S., Rinaldi, M., Fothergill, A., Gibbs, D. L. & Wang, A. (2007) Multicenter evaluation of a new disk agar diffusion method for susceptibility testing of filamentous fungi with voriconazole, posaconazole, itraconazole, amphotericin B, and caspofungin. J Clin Microbiol, 45, 1811–20.

    Article  CAS  PubMed  Google Scholar 

  44. Pfaller, J. B., Messer, S. A., Hollis, R. J., Diekema, D. J. & Pfaller, M. A. (2003) In vitro susceptibility testing of Aspergillus spp.: comparison of Etest and reference microdilution methods for determining voriconazole and itraconazole MICs. J Clin Microbiol, 41, 1126–9.

    Article  CAS  PubMed  Google Scholar 

  45. Clinical and Laboratory Standards Institute – CLSI. (2004) Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard M44-A, Villanova, Pa.

    Google Scholar 

  46. Espinel-Ingroff, A. & Rezusta, A. (2002) E-test method for testing susceptibilities of Aspergillus spp. to the new triazoles voriconazole and posaconazole and to established antifungal agents: comparison with NCCLS broth microdilution method. J Clin Microbiol, 40, 2101–7.

    Article  CAS  PubMed  Google Scholar 

  47. Sanchez, M. L. & Jones, R. N. (1993) E-test, an antimicrobial susceptibility testing method with broad clinical and epidemiologic application. Antimicrob Newsl, 8, 1–8.

    Article  Google Scholar 

  48. Clinical and Laboratory Standards Institute – CLSI. (2002) Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard M27-A2, 2a ed., 2002, Vilanova, Pa.

    Google Scholar 

  49. Espinel-Ingroff, A. (2003). Evaluation of broth microdilution testing parameters and agar diffusion Etest procedure for testing susceptibilities of Aspergillus spp. to caspofungin acetate (MK-0991). J Clin Microbiol, 41, 403–9.

    Article  CAS  PubMed  Google Scholar 

  50. Serrano, M. C., Ramírez, M., Morilla, D., Valverde, A., Chávez, M., Espinel-Ingroff, A., Claro, R., Fernández, A., Almeida, C. & Martín-Mazuelos, E. (2004). A comparative study of the disc diffusion method with the broth microdilution and E-test methods for voriconazole susceptibility testing of Aspergillus spp. J Antimicrob Chemother, 53, 739–42.

    Article  CAS  PubMed  Google Scholar 

  51. Guinea, J., Peláez, T., Alcalá, L. & Bouza, E. (2007) Correlation between the E test and the CLSI M-38 A microdilution method to determine the activity of amphotericin B, voriconazole, and itraconazole against clinical isolates of Aspergillus fumigatus. Diagn Microbiol Infect Dis, 57, 273–6.

    Article  CAS  PubMed  Google Scholar 

  52. Mallié, M., Bastide, J. M., Blancard, A., Bonnin, A., Bretagne, S., Cambon, M., Chandenier, J., Chauveau, V., Couprie, B., Datry, A., Feuilhade, M., Grillot, R., Guiguen, C., Lavarde, V., Letscher, V., Linas, M. D., Michel, A., Morin, O., Paugam, A., Piens, M. A., Raberin, H., Tissot, E., Toubas, D. & Wade, A. (2005) In vitro susceptibility testing of Candida and Aspergillus spp. to voriconazole and other antifungal agents using Etest: results of a French multicentre study. Int J Antimicrob Agents, 25, 321–8.

    Article  PubMed  Google Scholar 

  53. Marks, M. I. & Eickhoff, T. C. (1970) Application of four methods to the study of the susceptibility of yeast to 5-fluorocytosine. Antimicrob Agents Chemother, 10, 491–3.

    CAS  PubMed  Google Scholar 

  54. Grendahl, J. G. & Sung, J. P. (1978) Quantitation of imidazoles by agar-disk diffusion. Antimicrob Agents Chemother, 14, 509–13.

    CAS  PubMed  Google Scholar 

  55. Saubolle, M. A. & Hoeprich, P. D. (1978) Disk agar diffusion susceptibility testing of yeasts. Antimicrob Agents Chemother, 14, 517–30.

    CAS  PubMed  Google Scholar 

  56. Torres-Rodriguez, J. M., Sabaté, M., Gallach, C., Carrillo, A. & Madrenys, N. (1990) Sensibilidad in vitro a la 5-fluorocitosina y anfotericina B de levaduras del género Candida aisladas en Barcelona. Enf Infect Microbiol Clin, 8, 91–3.

    CAS  Google Scholar 

  57. Barry, A. L., Pfaller, M. A., Rennie, R. P., Fuchs, P. C. & Brown, S. D. (2002) Precision and accuracy of fluconazole susceptibility testing by broth microdilution, E-test, and disk diffusion methods. Antimicrob Agents Chemother, 46, 1781–4.

    Article  CAS  PubMed  Google Scholar 

  58. Colombo, A. L., Matta, D., Almeida, L.P. & Rosas, R. (2002) Fluconazole susceptibility of Brazilian Candida assessed by a disk diffusion method. Braz J Infect Dis, 6, 118–23.

    Article  PubMed  Google Scholar 

  59. Clinical and Laboratory Standards Institute – CLSI. (2003) Reference method for broth dilution antifungal susceptibility testing of yeasts. Proposed standard M44-P, Villanova, Pa.

    Google Scholar 

  60. Espinel-Ingroff, A. (2006). Comparison of three commercial assays and a modified disk diffusion assay with two broth microdilution reference assays for testing zygomycetes, Aspergillus spp., Candida spp., and Cryptococcus neoformans with posaconazole and amphotericin B. J Clin Microbiol, 44, 3616–22.

    Article  CAS  PubMed  Google Scholar 

  61. Espinel-Ingroff, A. & Canton, E. (2008) Comparison of Neo-Sensitabs tablet diffusion assay with CLSI broth microdilution M38-A and disk diffusion methods for testing susceptibility of filamentous fungi with amphotericin B, caspofungin, itraconazole, posaconazole, and voriconazole. J Clin Microbiol, 46, 1793–803.

    Article  CAS  PubMed  Google Scholar 

  62. Espinel-Ingroff, A., Pfaller, M., Messer, S. A., Knapp, C. C., Killian, S., Norris, H. A. & Ghannoum, M. A. (1999) Multicenter comparison of the sensititre YeastOne Colorimetric Antifungal Panel with the National Committee for Clinical Laboratory standards M27-A reference method for testing clinical isolates of common and emerging Candida spp., Cryptococcus spp., and other yeasts and yeast-like organisms. J Clin Microbiol, 37, 591–5.

    CAS  PubMed  Google Scholar 

  63. Pfaller, M. A., Espinel-Ingroff, A. & Jones, R. N. (2004) Clinical evaluation of the Sensititre YeastOne colorimetric antifungal plate for antifungal susceptibility testing of the new triazoles voriconazole, posaconazole, and ravuconazole. J Clin Microbiol, 42, 4577–80.

    Article  CAS  PubMed  Google Scholar 

  64. Castro, C., Serrano, M. C., Flores, B., Espinel-Ingroff, A. & Martín-Mazuelos, E. (2004) Comparison of the Sensititre YeastOne colorimetric antifungal panel with a modified NCCLS M38-A method to determine the activity of voriconazole against clinical isolates of Aspergillus spp. J Clin Microbiol, 42, 4358–60.

    Article  CAS  PubMed  Google Scholar 

  65. Linares, M. J., Charriel, G., Solís, F., Rodriguez, F., Ibarra, A. & Casal, M. (2005) Susceptibility of filamentous fungi to voriconazole tested by two microdilution methods. J Clin Microbiol, 43, 250–3.

    Article  CAS  PubMed  Google Scholar 

  66. Jahn, B., Martin, E., Stueben, A. & Bhakdi, S. (1995) Susceptibility testing of Candida albicans and Aspergillus species by a simple microtiter menadione-augmented 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide assay. J Clin Microbiol, 33, 661–7.

    CAS  PubMed  Google Scholar 

  67. Meletiadis, J., Meis, J. F. G. M., Mouton, J. W., Donnelly, J. P. & Verweij, P. E. (2000) Comparison of NCCLS and 3-(4,5-dimethyl-2-thiazyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) methods of in vitro susceptibility testing of filamentous fungi and development of a new simplified method. J Clin Microbiol, 38, 2949–54.

    CAS  PubMed  Google Scholar 

  68. Paull, D. K., Shoemaker, H. & Boyd, M. R. (1998) The synthesis of XTT: a new tetrazolium reagent that is bioreducible to a water-soluble formazan. J Heterocycl Chem, 25, 911–4.

    Article  Google Scholar 

  69. Sugar, A. M. & Liu, X. (1995) Comparison of three methods of antifungal susceptibility testing with the proposed NCCLS standard broth macrodilution assay: lack of effect of phenol red. Diagn Microbiol Infect Dis, 21, 129–33.

    Article  CAS  PubMed  Google Scholar 

  70. Antachopoulos, C., Meletiadis, J., Sein, T., Roilides, E. & Walsh, T. J. (2007) Use of high inoculum for early metabolic signalling and rapid susceptibility testing of Aspergillus species. J Antimicrob Chemother, 59, 230–7.

    Article  CAS  PubMed  Google Scholar 

  71. Araujo, R., Coutinho, I. & Espinel-Ingroff, A. (2008) Rapid method for testing the susceptibility of Aspergillus fumigatus to amphotericin B, itraconazole, voriconazole and posaconazole by assessment of oxygen consumption. J Antimicrob Chemother, 62, 1277–80.

    Article  CAS  PubMed  Google Scholar 

  72. Ansheng, L., Taguchi, H., Miyaji, M., Nishimura, K. & Wu, S. (1999) Study on the hyphal responses of Aspergillus fumigatus to the antifungal agent by Bio-Cell Tracer. Mycopathologia, 148, 17–23.

    Article  CAS  PubMed  Google Scholar 

  73. Taguchi, H., Miyaji, M. & Yoshida, T. (2000) Evaluation of miconazole activity contained in human serum to hypha of Aspergillus fumigatus. Nippon Ishinkin Gakkai Zasshi, 41, 41–4.

    Article  CAS  PubMed  Google Scholar 

  74. Vale-Silva, L. A. & Buchta, V. (2006) Antifungal susceptibility testing by flow cytometry: is it the future? Mycoses, 49, 261–73.

    Article  CAS  PubMed  Google Scholar 

  75. Ramani, R., Gangwar, M. & Chaturvedi, V. (2003) Flow cytometry antifungal susceptibility testing of Aspergillus fumigatus and comparison of mode of action of voriconazole vis-à-vis amphotericin B and itraconazole. Antimicrob Agents Chemother, 47, 3627–9.

    Article  CAS  PubMed  Google Scholar 

  76. Garcia-Effron, G., Dilger, A., Alcazar-Fuoli, L., Park, S., Mellado, E., Perlin, D. S. (2008) Rapid detection of triazole antifungal resistance in Aspergillus fumigatus. J Clin Microbiol, 46, 1200–6.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Arnaldo Lopes Colombo .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer Science+Business Media B.V.

About this chapter

Cite this chapter

Colombo, A.L., Reis, V., Godoy, P. (2009). Antifungal Susceptibility Tests of Aspergillus Species. In: Comarú Pasqualotto, A. (eds) Aspergillosis: From Diagnosis to Prevention. Springer, Dordrecht. https://doi.org/10.1007/978-90-481-2408-4_13

Download citation

Publish with us

Policies and ethics